Genomics and multi-omics companies develop technologies, services and analytical platforms that help researchers and clinicians understand biological systems at the DNA, RNA, protein and cellular level. The field underpins advances in precision medicine, drug discovery, diagnostics, agriculture and biotechnology.
This category includes companies working on:
Browse 190 UK genomics and multi-omics companies below.
Patient-controlled DNA biobank platform for precision prescribing insights
GeneHub is a London-based digital health company operating a patient-controlled biobank platform that rewards patients with free DNA tests and insights in exchange for sharing anonymised genetic data with researchers and clinicians. The platform aims to support precision prescribing, helping reduce adverse drug…
Contract genomics services including Sanger and next-generation sequencing
GENEWIZ is a genomics services company and providing Sanger sequencing, next-generation sequencing, gene synthesis, oligo synthesis and bioinformatics services to pharmaceutical, biotechnology and academic customers worldwide. Its services span whole genome sequencing, RNA-seq, single-cell sequencing, metagenomics and…
Molecular diagnostic kits and genomic services for clinical laboratories
Yourgene Health is a molecular diagnostics company developing, manufacturing and commercialising IVD reagent kits and genomic services for reproductive health, precision medicine and infectious disease. Its product portfolio includes NGS-based non-invasive prenatal testing kits, cystic fibrosis screening assays,…
Graph AI platform for crop gene target discovery and precision breeding
Biographica is a London agbiotech developing a graph machine learning platform to identify and validate gene editing targets for crop improvement. The platform integrates genomic, transcriptomic, and scientific literature data within knowledge graphs, combining in silico modelling with in vivo validation at Rothamsted…
Targeted transcriptomic sequencing services for diagnostics and drug discovery
BioClavis is a genomics R&D and services laboratory leveraging their targeted RNA sequencing platform for high-throughput transcriptomic and biomarker analysis. The platform enables customisable gene expression profiling from crude cell lysates and archival FFPE tissue without nucleic acid purification, making it…
Molecular serotyping microarrays and surveillance services for vaccine pathogens
BUGS Bioscience is a not-for-profit biotechnology spin-out of the Bacterial Microarray Group at St George's, University of London. The company develops and provides molecular serotyping microarray platforms and associated genomic surveillance services for vaccine-preventable bacterial pathogens, including…
Fragment-based drug discovery with a glioblastoma focus
IOTA Pharmaceuticals is a Cambridge drug discovery company specialising in fragment-based design, molecular screening and computational approaches to early-stage therapeutics. Its research combines transcriptomics, phenotypic assays and natural product screening to investigate candidate treatments. A major focus is…
AAV gene therapy company targeting inherited and common retinal diseases
Beacon Therapeutics is a clinical-stage UK biopharma company developing adeno-associated virus (AAV) gene therapies for retinal diseases causing blindness. Its lead programme, laru-zova (AGTC-501), is in Phase II/III clinical trials for X-linked retinitis pigmentosa. The pipeline also includes preclinical programmes…
University spatial transcriptomics and imaging platform for tissue research
The DRP Spatial Platform is a university core facility that supports spatial transcriptomics and imaging projects. It offers experimental design, histology and sample preparation, tissue imaging and laser capture microdissection, and spatial gene expression profiling, with support for data quality control and…
Animal genetics company applying genomics and gene editing to livestock
Genus plc specialises in the genetic improvement of livestock through genomic selection and gene editing. Its commercial divisions supply semen and embryos from elite cattle and genetically superior breeding pigs to producers globally. Its R&D programme applies CRISPR-based precision breeding to improve disease…
External quality assessment for clinical genomics laboratories
GenQA is a not-for-profit provider of external quality assessment and proficiency testing for clinical genomics laboratories. Its schemes assess analytical and interpretive performance across next-generation sequencing, molecular pathology, reproductive genetics, pharmacogenomics and inherited disease testing. The…
Preimplantation and prenatal genetic testing for reproductive medicine
Juno Genetics is a specialist reproductive genetics laboratory providing preimplantation genetic testing (PGT) services to IVF clinics in the UK and internationally. Using its proprietary next-generation sequencing platform, the company screens embryos for chromosomal abnormalities and single-gene disorders, and…
Genetic insights to guide drug discovery and development
Sequoia Genetics is a contract research organisation applying human genetic data to inform drug discovery and clinical development. The company works with pharmaceutical companies, biotechnology firms, investors, and academic institutions to generate and interpret genetic insights that can guide target validation and…
Microbiology services and UK national bacterial culture collection
NCIMB is a UK microbiology services company and custodian of the National Collection of Industrial, Food and Marine Bacteria, the UK's largest public bacterial culture collection with over 10,000 strains. The company provides GMP-compliant microbial identification, whole genome sequencing, microbial community…
Federated genomic data analysis platform for research and drug discovery
Omecu is a software company developing a high-performance, federated genomics data analysis platform. Its computation engine enables researchers to query and analyse millions of genomic records across distributed datasets in seconds, without requiring data to leave its source institution, addressing the privacy and…
Cancer Research UK's translational and commercialisation arm
Cancer Research Horizons is the translational subsidiary of Cancer Research UK, operating at the interface between academic research and industry. The organisation combines in-house drug discovery expertise across six UK sites with technology transfer, licensing, and early-stage venture investment activities. It…
AI-driven isoform sequencing platform for movement disorder and ageing research
Entelo Bio is an Oxford-based biotechnology company developing a proprietary single-cell isoform sequencing and AI platform to decode disease biology in conditions affecting human movement and ageing. Built on research from the University of Oxford's Botnar Institute for Musculoskeletal Sciences, the platform combines…
Light-controlled droplet microfluidics for single-cell functional analysis
Lightcast Discovery is a life science tools company developing a droplet-based system for single-cell functional analysis. Using light to precisely control picolitre-scale droplets, the platform enables parallel interrogation of tens of thousands of individual cells across a range of functional assays, including…
High molecular weight DNA extraction kits for long-read sequencing
RevoluGen is a developer of molecular tools for isolating long, high-purity DNA from cells for sequencing and genomic analysis. The company's patented nucleic acid isolation technology extracts and size-selects long DNA fragments suited to long-read sequencing, genome assembly and long-range PCR, and is available as…
Early phase clinical trial CRO based at London Bridge
Richmond Pharmacology is a contract research organisation specialising in early phase and first-in-human clinical trials for pharmaceutical and biotech companies. Operating from hospital-adjacent facilities at London Bridge and St George's University London, the company has conducted over 20% of all UK Phase I studies…